Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01083849
What this trial is testing

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Who this might be right for
Kidney InsufficiencySecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 761
Testing effectiveness (Phase 2)Study completedNCT00003158
What this trial is testing

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 96
Early research (Phase 1)Ended earlyNCT00932126
What this trial is testing

This Is The First Study Using Escalating Doses Of PF-03758309, An Oral Compound, In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 35
Not applicableUnknownNCT03523078
What this trial is testing

Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy

Who this might be right for
Breast Cancer Female
Yonsei University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04486378
What this trial is testing

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IIColorectal Cancer Stage III
BioNTech SE 327
Early research (Phase 1)Looking for participantsNCT04186585
What this trial is testing

Recommended Dose Estimation of BP-C2

Who this might be right for
Prostate Cancer
Meddoc 8
Testing effectiveness (Phase 2)Study completedNCT02439385
What this trial is testing

Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis

Who this might be right for
Colorectal Cancer
Gachon University Gil Medical Center 44
Not applicableStudy completedNCT03534843
What this trial is testing

A Comparison Between Child-Pugh and Albumin-Bilirubin Scores

Who this might be right for
Rupture, SpontaneousRupture LiverHepatocellular Carcinoma+1 more
Huazhong University of Science and Technology 230
Testing effectiveness (Phase 2)Study completedNCT00065143
What this trial is testing

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06860815
What this trial is testing

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Carcinoma in the Liver
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT01271725
What this trial is testing

LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 74
Very early researchEnded earlyNCT07108140
What this trial is testing

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Who this might be right for
Solid Tumor
TCRCure Biopharma Ltd. 5
Testing effectiveness (Phase 2)Ended earlyNCT00538291
What this trial is testing

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

Who this might be right for
Colorectal Cancer
City of Hope Medical Center 13
Not applicableLooking for participantsNCT07263074
What this trial is testing

Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories

Who this might be right for
Myeloid Malignancy
University of Rochester 120
Early research (Phase 1)Study completedNCT05279690
What this trial is testing

Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors

Who this might be right for
Urothelial CancerMetastatic Solid Tumor
Icahn School of Medicine at Mount Sinai 16
Large-scale testing (Phase 3)Looking for participantsNCT06071897
What this trial is testing

Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma

Who this might be right for
NeuroblastomaGanglioneuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Large-scale testing (Phase 3)Study completedNCT02272413
What this trial is testing

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 671
Large-scale testing (Phase 3)Looking for participantsNCT05946213
What this trial is testing

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
NRG Oncology 1,209
Not applicableUnknownNCT01543620
What this trial is testing

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Foundation for the National Institutes of Health 150
Large-scale testing (Phase 3)UnknownNCT05783882
What this trial is testing

Prolgolimab 250 mg Q3W in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Biocad 114
Next Page